Cargando…
Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response: Challenges, Obstacles and Future Perspectives
This hypothesis proposal addresses three major questions: (1) Why do we need imaging biomarkers for assessing the efficacy of immune system participation in glioblastoma therapy response? (2) Why are they not available yet? and (3) How can we produce them? We summarize the literature data supporting...
Autores principales: | Candiota, Ana Paula, Arús, Carles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950145/ https://www.ncbi.nlm.nih.gov/pubmed/35323686 http://dx.doi.org/10.3390/metabo12030243 |
Ejemplares similares
-
Anti-PD-1 Immunotherapy in Preclinical GL261 Glioblastoma: Influence of Therapeutic Parameters and Non-Invasive Response Biomarker Assessment with MRSI-Based Approaches
por: Wu, Shuang, et al.
Publicado: (2020) -
Immune System-Related Changes in Preclinical GL261 Glioblastoma under TMZ Treatment: Explaining MRSI-Based Nosological Imaging Findings with RT-PCR Analyses
por: Calero-Pérez, Pilar, et al.
Publicado: (2021) -
Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?
por: Alfonso-Triguero, Paula, et al.
Publicado: (2023) -
Targeting ligand-gated ion channels in neurology and psychiatry: is pharmacological promiscuity an obstacle or an opportunity?
por: Bianchi, Matt T, et al.
Publicado: (2010) -
Under-representation of PolyA/PolyT tailed ESTs in Human ESTdb: an obstacle to alternative polyadenylation inference
por: Gilat, Roi, et al.
Publicado: (2006)